1,898
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Ginsenoside Rb1 attenuates age-associated vascular impairment by modulating the Gas6 pathway

, , , , , & show all
Pages 1367-1375 | Received 18 Apr 2021, Accepted 22 Sep 2021, Published online: 09 Oct 2021

References

  • Acosta JC, O’Loghlen A, Banito A, Guijarro MV, Augert A, Raguz S, Fumagalli M, Da Costa M, Brown C, Popov N, et al. 2008. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell. 133(6):1006–1018.
  • Brandes RP, Fleming I, Busse R. 2005. Endothelial aging. Cardiovasc Res. 66(2):286–294.
  • Chen FF, Song FQ, Chen YQ, Wang ZH, Li YH, Liu MH, Li Y, Song M, Zhang W, Zhao J, et al. 2019. Exogenous testosterone alleviates cardiac fibrosis and apoptosis via Gas6/Axl pathway in the senescent mice. Exp Gerontol. 119:128–137.
  • Chen YQ, Zhao J, Jin CW, Li YH, Tang MX, Wang ZH, Zhang W, Zhang Y, Li L, Zhong M. 2016. Testosterone delays vascular smooth muscle cell senescence and inhibits collagen synthesis via the Gas6/Axl signaling pathway. Age. 38(3):60.
  • Fridell YW, Villa J, Attar EC, Liu ET. 1998. GAS6 induces Axl-mediated chemotaxis of vascular smooth muscle cells. J Biol Chem. 273(12):7123–7126.
  • Gong X, Ma Y, Ruan Y, Fu G, Wu S. 2014. Long-term atorvastatin improves age-related endothelial dysfunction by ameliorating oxidative stress and normalizing eNOS/iNOS imbalance in rat aorta. Exp Gerontol. 52:9–17.
  • Harvey A, Montezano AC, Lopes RA, Rios F, Touyz RM. 2016. Vascular fibrosis in aging and hypertension: molecular mechanisms and clinical implications. Can J Cardiol. 32(5):659–668.
  • Herrera MD, Mingorance C, Rodriguez-Rodriguez R, Alvarez de Sotomayor M. 2010. Endothelial dysfunction and aging: an update. Ageing Res Rev. 9(2):142–152.
  • Hsu JJ, Lu J, Umar S, Lee JT, Kulkarni RP, Ding Y, Chang CC, Hsiai TK, Hokugo A, Gkouveris I, Tetradis S, et al. 2018. Effects of teriparatide on morphology of aortic calcification in aged hyperlipidemic mice. Am J Physiol Heart Circ Physiol. 314(6):H1203–H1213.
  • Hurtado B, Abasolo N, Munoz X, Garcia N, Benavente Y, Rubio F, Garcia de Frutos P, Krupinski J, Sala N. 2010. Association study between polymorphims in GAS6-TAM genes and carotid atherosclerosis. Thromb Haemost. 104(3):592–598.
  • Intengan HD, Thibault G, Li JS, Schiffrin EL. 1999. Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats: effects of angiotensin receptor antagonism and converting enzyme inhibition. Circulation. 100(22):2267–2275.
  • Iyemere VP, Proudfoot D, Weissberg PL, Shanahan CM. 2006. Vascular smooth muscle cell phenotypic plasticity and the regulation of vascular calcification. J Intern Med. 260(3):192–210.
  • Kaesler N, Immendorf S, Ouyang C, Herfs M, Drummen N, Carmeliet P, Vermeer C, Floege J, Kruger T, Schlieper G. 2016. Gas6 protein: its role in cardiovascular calcification. BMC Nephrol. 17(1):52.
  • Kim EN, Kim MY, Lim JH, Kim Y, Shin SJ, Park CW, Kim YS, Chang YS, Yoon HE, Choi BS. 2018. The protective effect of resveratrol on vascular aging by modulation of the renin-angiotensin system. Atherosclerosis. 270:123–131.
  • Korshunov VA, Mohan AM, Georger MA, Berk BC. 2006. Axl, a receptor tyrosine kinase, mediates flow-induced vascular remodeling. Circ Res. 98(11):1446–1452.
  • Kovacic JC, Moreno P, Hachinski V, Nabel EG, Fuster V. 2011. Cellular senescence, vascular disease, and aging: Part 1 of a 2-part review. Circulation. 123(15):1650–1660.
  • Kwok HH, Yue PY, Mak NK, Wong RN. 2012. Ginsenoside Rb1 induces type I collagen expression through peroxisome proliferator-activated receptor-delta. Biochem Pharmacol. 84(4):532–539.
  • Lacolley P, Regnault V, Avolio AP. 2018. Smooth muscle cell and arterial aging: basic and clinical aspects. Cardiovasc Res. 114(4):513–528.
  • Lakatta EG, Levy D. 2003. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a “set up” for vascular disease. Circulation. 107(1):139–146.
  • Liu H, Wang H, Yang S, Qian D. 2019. Downregulation of miR-542-3p promotes osteogenic transition of vascular smooth muscle cells in the aging rat by targeting BMP7. Hum Genomics. 13(1):67.
  • Mauriello A, Orlandi A, Palmieri G, Spagnoli LG, Oberholzer M, Christen H. 1992. Age-related modification of average volume and anisotropy of vascular smooth muscle cells. Pathol Res Pract. 188(4–5):630–636.
  • McClelland RL, Chung H, Detrano R, Post W, Kronmal RA. 2006. Distribution of coronary artery calcium by race, gender, and age: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 113(1):30–37.
  • McEniery CM, Yasmin Hall IR, Qasem A, Wilkinson IB, Cockcroft JR, Investigators A. 2005. Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol. 46:1753–1760.
  • Miao HH, Zhang Y, Ding GN, Hong FX, Dong P, Tian M. 2017. Ginsenoside Rb1 attenuates isoflurane/surgery-induced cognitive dysfunction via inhibiting neuroinflammation and oxidative stress. Biomed Environ Sci. 30(5):363–372.
  • Minamino T, Komuro I. 2007. Vascular cell senescence: contribution to atherosclerosis. Circ Res. 100(1):15–26.
  • Moslehi J, DePinho RA, Sahin E. 2012. Telomeres and mitochondria in the aging heart. Circ Res. 110(9):1226–1237.
  • Nakano T, Ishimoto Y, Kishino J, Umeda M, Inoue K, Nagata K, Ohashi K, Mizuno K, Arita H. 1997. Cell adhesion to phosphatidylserine mediated by a product of growth arrest-specific gene 6. J Biol Chem. 272(47):29411–29414.
  • Nakano-Kurimoto R, Ikeda K, Uraoka M, Nakagawa Y, Yutaka K, Koide M, Takahashi T, Matoba S, Yamada H, Okigaki M, et al. 2009. Replicative senescence of vascular smooth muscle cells enhances the calcification through initiating the osteoblastic transition. Am J Physiol Heart Circ Physiol. 297(5):H1673–1684.
  • Nanao-Hamai M, Son BK, Komuro A, Asari Y, Hashizume T, Takayama KI, Ogawa S, Akishita M. 2019. Ginsenoside Rb1 inhibits vascular calcification as a selective androgen receptor modulator. Eur J Pharmacol. 859:172546.
  • O’Rourke MF, Safar ME, Dzau V. 2010. The Cardiovascular Continuum extended: aging effects on the aorta and microvasculature. Vasc Med. 15(6):461–468.
  • Qin Q, Mehta H, Yen K, Navarrete G, Brandhorst S, Wan J, Delrio S, Zhang X, Lerman LO, Cohen P, et al. 2018. Chronic treatment with the mitochondrial peptide humanin prevents age-related myocardial fibrosis in mice. Am J Physiol Heart Circ Physiol. 315(5):H1127–H1136.
  • Rothlin CV, Carrera-Silva EA, Bosurgi L, Ghosh S. 2015. TAM receptor signaling in immune homeostasis. Annu Rev Immunol. 33:355–391.
  • Son BK, Akishita M, Iijima K, Ogawa S, Maemura K, Yu J, Takeyama K, Kato S, Eto M, Ouchi Y. 2010. Androgen receptor-dependent transactivation of growth arrest-specific gene 6 mediates inhibitory effects of testosterone on vascular calcification. J Biol Chem. 285(10):7537–7544.
  • Sun X, Guan H, Peng S, Zhao Y, Zhang L, Wang X, Li C, Shan Z, Teng W. 2019. Growth arrest-specific protein 6 (Gas6) attenuates inflammatory injury and apoptosis in iodine-induced NOD.H-2h4 mice. Int Immunopharmacol. 73:333–342.
  • Tesauro M, Mauriello A, Rovella V, Annicchiarico-Petruzzelli M, Cardillo C, Melino G, Di Daniele N. 2017. Arterial ageing: from endothelial dysfunction to vascular calcification. J Intern Med. 281(5):471–482.
  • Tolle M, Reshetnik A, Schuchardt M, Hohne M, van der Giet M. 2015. Arteriosclerosis and vascular calcification: causes, clinical assessment and therapy. Eur J Clin Invest. 45(9):976–985.
  • Wang M, Jiang L, Monticone RE, Lakatta EG. 2014. Proinflammation: the key to arterial aging. Trends Endocrinol Metab. 25(2):72–79.
  • Wang M, Spinetti G, Monticone RE, Zhang J, Wu J, Jiang L, Khazan B, Telljohann R, Lakatta EG. 2011. A local proinflammatory signalling loop facilitates adverse age-associated arterial remodeling. PLoS One. 6(2):e16653.
  • Wendorff C, Wendorff H, Pelisek J, Tsantilas P, Zimmermann A, Zernecke A, Kuehnl A, Eckstein HH. 2015. Carotid plaque morphology is significantly associated with sex, age, and history of neurological symptoms. Stroke. 46(11):3213–3219.
  • Yanagita M, Arai H, Ishii K, Nakano T, Ohashi K, Mizuno K, Varnum B, Fukatsu A, Doi T, Kita T. 2001. Gas6 regulates mesangial cell proliferation through Axl in experimental glomerulonephritis. Am J Pathol. 158(4):1423–1432.
  • Yang D, Xiao C, Long F, Wu W, Huang M, Qu L, Liu X, Zhu Y. 2019. Fra-1 plays a critical role in angiotensin II-induced vascular senescence. FASEB J. 33(6):7603–7614.
  • Zheng X, Wang S, Zou X, Jing Y, Yang R, Li S, Wang F. 2017. Ginsenoside Rb1 improves cardiac function and remodeling in heart failure. Exp Anim. 66(3):217–228.
  • Zheng Z, Wang M, Cheng C, Liu D, Wu L, Zhu J, Qian X. 2020. Ginsenoside Rb1 reduces H2O2-induced HUVEC dysfunction by stimulating the sirtuin-1/AMP-activated protein kinase pathway. Mol Med Rep. 22(1):247–256.
  • Zhou J, Walker A. 2021. The impact of community care services on the preference for ageing in place in urban China. Health Soc Care Community. 29(4):1041–1050.
  • Zhou P, Lu S, Luo Y, Wang S, Yang K, Zhai Y, Sun G, Sun X. 2017. Attenuation of TNF-α-induced inflammatory injury in endothelial cells by ginsenoside Rb1 via inhibiting NF-κB, JNK and p38 signaling pathways. Front Pharmacol. 8:464.
  • Zhou P, Xie WJ, He SB, Sun YF, Meng XB, Sun GB. 2019a. Ginsenoside Rb1 as an anti-diabetic agent and its underlying mechanism analysis. Cells. 8:204.
  • Zhou P, Zhang X, Guo M, Guo R, Wang L, Zhang Z, Lin Z, Dong M, Dai H, Ji X, et al. 2019b. Ginsenoside Rb1 ameliorates CKD-associated vascular calcification by inhibiting the Wnt/β-catenin pathway. J Cell Mol Med. 23(10):7088–7098.